Author:
Ozdemir Filiz Arioz,Anilanmert Beril,Pekin Mursit
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference19 articles.
1. Chen X, Oza AM, Kusenda Z, et al (2003) Phase I study of cisplatin, irinotecan and epirubicin administered every two weeks in patients with advanced solid tumours. Br J Cancer 89(4):617–624
2. Chollet DF, Goumaz L, Renard A, et al (1998) Simultaneous determination of the lactone and carboxylate forms of the camptothecin derivative CPT-11 and its metabolite SN-38 in plasma by high performance liquid chromatography. J Chromatogr B 718:163–175
3. Cohen MH, Johnston-Early A, Hood MA, et al (1985) Drug precipitation within IV tubing: a potential hazard of chemotherapy administration. Cancer Treat Rep 69:1325–1326
4. Ellence (1999) Epirubicin hydrochloride injection, revised package insert. Pharmacia & Upjohn, Perth
5. Hwang JJ, Marshall JL, Rizvi N (2003) Combined inhibition of topoisomerases: a phase 1 study of irinotecan and epirubicin. Oncology 17 [Suppl 5]:S46–S51
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献